These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 869702)

  • 1. [Comparative human studies of a new anti-hypertensive drug (2,6-dichloro-benzylidene-aminoguanidine acetate) and methyldopa in hypertensive patients].
    Baldrighi V; Baldrighi G; Ronzoni L; Aiazzi L; Caprioli G
    Arch Sci Med (Torino); 1977; 134(2):185-92. PubMed ID: 869702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antihypertensive activity of a new molecule, 2,6-dichloro-benzylidene aminoguanidine acetate].
    Chiummo R
    Minerva Med; 1975 Dec; 66(84):4546-50. PubMed ID: 1202408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative antihypertensive effects of guanabenz and methyldopa.
    Walker BR; Deitch MW; Schneider BE; Hare LE
    Clin Ther; 1981; 4(4):275-84. PubMed ID: 7332915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The antihypertensive effect of 2,6-dichloro-benzylidene-aminoguanidine acetate (Guanabenz)].
    Chiarini C; Degli Esposti E; Gattiani A; Sturani A; Zuccalá A
    G Clin Med; 1980 Mar; 61(3):231-6. PubMed ID: 6993277
    [No Abstract]   [Full Text] [Related]  

  • 5. Guanabenz versus methyldopa in the therapy of mild-to-moderate hypertension.
    Rosendorff C
    S Afr Med J; 1982 Sep; 62(13):435-7. PubMed ID: 7051365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guanabenz and methyldopa on hypertension and cardiac performance.
    Walker BR; Shah RS; Ramanathan KB; Vanov SK; Helfant RH
    Clin Pharmacol Ther; 1977 Dec; 22(6):868-74. PubMed ID: 336257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of guanabenz in hypertensive patients with moderate renal insufficiency.
    Dubrow A; Mittman N; DeCola P; Westerman M; Flamenbaum W
    J Clin Hypertens; 1985 Dec; 1(4):322-5. PubMed ID: 3836301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-hypertensive effectiveness of guanfacine and methyldopa: comparison of groups of patients].
    Malini PL; Strocchi E; Ambrosioni E; Magnani B
    Cardiologia; 1982; 27(4):357-63. PubMed ID: 6765262
    [No Abstract]   [Full Text] [Related]  

  • 9. [A new guanabenz-mefruside drug in the treatment of arterial hypertension].
    Buemi M; Macrì I; Ussi F; Frisina N
    Minerva Cardioangiol; 1985; 33(1-2):73-80. PubMed ID: 4010975
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of guanabenz on plasma renin and aldosterone and on sodium balance in hypertensive patients].
    Bevilacqua M; Meroni R; Scorza D; Vago T; Norbiato G
    Minerva Cardioangiol; 1984 May; 32(5):267-71. PubMed ID: 6382053
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of guanabenz therapy on renal function and body fluid composition.
    Bauer JH
    Arch Intern Med; 1983 Jun; 143(6):1163-7. PubMed ID: 6860045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of arterial hypertension with a new drug combining guanabenz-mefruside].
    Frisina N; Macrì I; Ussi F
    Minerva Cardioangiol; 1984 May; 32(5):325-32. PubMed ID: 6382057
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anti-hypertensive efficacy of guanfacine and methyldopa: intra-patient comparison].
    Malini PL; Strocchi E; Ambrosioni E; Magnani B
    Cardiologia; 1982; 27(4):357-63. PubMed ID: 6765437
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical and fundamental study of guanabenz in hypertensive patients with renal failure].
    Nishio S; Hayashi S; Yoshihara H
    Hinyokika Kiyo; 1988 Jun; 34(6):1083-9. PubMed ID: 3223454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of guanabenz alone and in association with a diuretic on blood pressure and on the renin-angiotensin-aldosterone system in hypertensive patients].
    Madeddu P; Glorioso N; Dessì-Fulgheri P; Rappelli A; Delle Gemme E
    Minerva Cardioangiol; 1984 May; 32(5):281-4. PubMed ID: 6382055
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of guanabenz on arterial pressure and the renin-aldosterone system in hypertensive patients].
    Rappelli A; Glorioso N; Tedde R; Madeddu P; Dessì Fulgheri P; Campus S
    Boll Soc Ital Cardiol; 1978; 23(1):177-83. PubMed ID: 754771
    [No Abstract]   [Full Text] [Related]  

  • 17. [Double-blind assay of a new hypotensive agent of central action, guanfacine, compared with alpha-methyldopa].
    Jiménez Casado M; Canto J; Yapur H; Oller JM
    Rev Clin Esp; 1984 Jul 15-31; 174(1-2):41-4. PubMed ID: 6393236
    [No Abstract]   [Full Text] [Related]  

  • 18. [A clinical trial of guanoxabenz: a hypotensive agent with central and hypertensive action (author's transl)].
    Ledoux F; Welsch M; Steimer C; Schwartz J
    Therapie; 1981; 36(2):187-91. PubMed ID: 7027519
    [No Abstract]   [Full Text] [Related]  

  • 19. Guanabenz in essential hypertension.
    McMahon FG; Ryan JR; Jain AK; Vargas R; Vanov SK
    Clin Pharmacol Ther; 1977 Mar; 21(3):272-7. PubMed ID: 319938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of idiopathic hypertension with guanabenz-mefruside].
    Tomasi AM; Pirani R; Masoni C
    Minerva Cardioangiol; 1984 May; 32(5):339-44. PubMed ID: 6382059
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.